Comparing Lemborexant vs Suvorexant
| Lemborexant | Suvorexant |
|
|---|
| Lemborexant | Suvorexant |
|
|---|---|---|
|
Prescription only
Prescribed for Insomnia. Lemborexant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Suvorexant may also be used for purposes not listed in this medication guide. |
Related suggestions Insomnia
|
| More about Lemborexant | More about Suvorexant | |
| Ratings & Reviews | ||
|
Lemborexant has an average rating of 5.3 out of 10 from a total of 305 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 44% reported a negative effect. |
Suvorexant has an average rating of 3.9 out of 10 from a total of 571 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 61% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Lemborexant side effects |
View all Suvorexant side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Dayvigo | Belsomra | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
19 hours |
12 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 468 drugs are known to interact with Lemborexant:
|
A total of 499 drugs are known to interact with Suvorexant:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
||
| Disease Interactions | ||
| First Approval Date | ||
|
December 20, 2019 |
August 13, 2014 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.